|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07F 5/04 | (2006.01) |
| A61K 31/69 | (2013.01) | ||
| A61K 31/69 | (2006.01) | ||
| C07F 5/025 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07B2200/13 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3798224 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20207885.3 |
| Europos patento paraiškos padavimo data | 2017-06-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-03-31 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-03-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201662352787 P | 2016-06-21 | US | |
| 201662438073 P | 2016-12-22 | US |
| (72) |
VALIK, Martin , CZ
GABRIEL, Roman , CZ
VRASPIR, Pavel , CZ
LUKAS, David , CZ
|
| (73) |
Assia Chemical Industries LTD ,
Dvora Hanevi'a 124, 6944020 Tel Aviv,
IL
|
| (54) | SOLID STATE FORMS OF IXAZOMIB CITRATE |
| SOLID STATE FORMS OF IXAZOMIB CITRATE |